Antibiotic Utilization Strategies to Limit Antimicrobial Resistance

ABSTRACT

Antimicrobial resistance is now being recognized as a major factor determining morbidity, mortality, and cost in the intensive care unit (ICU). Various strategies to limit its spread have evolved with our understanding and are based on four basic principles: infection prevention, infection eradication, containment of resistant species, and optimization of antibiotic utilization. The optimization of antibiotic utilization, at its most basic level, is the appropriate use of antibiotics and the limitation of unnecessary antibiotic administration/exposure consisting of appropriate diagnosis, acquiring appropriate culture and sensitivity data, implementing the most appropriate treatment, selecting appropriate antibiotics, and dosing appropriately. In addition various antibiotic utilization strategies including antibiotic utilization guidelines, formulary restriction, and antibiotic cycling or rotation have evolved from our understanding of the impact of changes in antibiotic utilization on subsequent antibiotic susceptibility patterns. These strategies can be utilized as a part of a multidisciplinary approach to limit the appearance and dissemination of antimicrobial resistance in our ICUs.

KEYWORDS

Antibiotics - antibiotic resistance - antibiotic cycling

REFERENCES

• 1 Weinstein R A. Nosocomial infection update.  Emerg Infect Dis . 1998;  4 416-420
• 2 Jones R N. Resistance patterns among nosocomial pathogens: trends over the past few years.  Chest . 2001;  S397-S404
• 3 Jones R N, Pfaller M A. Bacterial resistance: a worldwide problem.  Diagn Microbiol Infect Dis . 1998;  31 379-388
• 4 Cohen M L. Epidemiology of drug resistance: implications for a post-antimicrobial era.  Science . 1992;  257 1050-1055
• 5 Acar J F. Consequences of bacterial resistance to antibiotics in medical practice.  Clin Infect Dis . 1997;  S17-S18
• 6 Acar J F, Goldstein F W. Consequences of increasing resistance to antimicrobial agents.  Clin Infect Dis . 1998;  S125-S130
• 7 Carbon C. Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci.  J Antimicrob Chemother . 1999;  S31-S36
• 8 Gleason T G, Crabtree T D, Pelletier S J. Prediction of poorer prognosis by infection with antibiotic-resistant gram-positive cocci than by infection with antibiotic-sensitive strains.  Arch Surg . 1999;  134 1033-1040
• 9 Shlaes D M, Gerding D N, John Jr F J. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.  Clin Infect Dis . 1997;  25 584-599
• 10 Goldmann D A, Weinstein R A, Wenzel R P. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership.  JAMA . 1996;  275 234-240
• 11 Gorecki P, Schein M, Rucinski J C, Wise L. Antibiotic administration in patients undergoing common surgical procedures in a community teaching hospital: the chaos continues.  World J Surg . 1999;  23 429-433
• 12 Dunagan W C, Woodward R S, Medoff G. Antibiotic misuse in two clinical situations: positive blood culture and administration of aminoglycosides.  Rev Infect Dis . 1991;  13 405-412
• 13 Lee K R, Leggiadro R J, Burch K J. Drug use evaluation of antibiotics in a pediatric teaching hospital.  Infect Control Hosp Epidemiol . 1994;  15 710-712
• 14 Edmond M B, Ober J F, Weinbaum D L. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.  Clin Infect Dis . 1995;  20 1126-1133
• 15 Fagon J Y, Chastre J, Domart Y. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques.  Am Rev Respir Dis . 1989;  139 877-884
• 16 Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.  Chest . 1993;  104 1230-1235
• 17 Chow J W, Fine M J, Shlaes D M. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.  Ann Intern Med . 1991;  115 585-590
• 18 Kollef M H, Silver P, Murphy D M, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality.  Chest . 1995;  108 1655-1662
• 19 Gerding D N, Larson T A, Hughes R A, Weiler M, Shanholtzer C, Peterson L R. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital.  Antimicrob Agents Chemother . 1991;  35 1284-1290
• 20 Kollef M H, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.  Am J Respir Crit Care Med . 1997;  156 1040-1048
• 21 Rahal J J, Urban C, Horn D. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella JAMA .  1998;  280 1233-1237
• 22 Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci.  Clin Infect Dis . 1996;  23 1020-1025
• 23 Landman D, Chockalingam M, Quale J M. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary.  Clin Infect Dis . 1999;  28 1062-1066
• 24 Molstad S, Cars O. Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA).  Scand J Infect Dis . 1999;  31 191-195
• 25 Seppala H, Klaukka T, Vuopio-Varkila J. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.  N Engl J Med . 1997;  337 441-446
• 26 Gruson D, Hilbert G, Vargas F. Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.  Am J Respir Crit Care Med . 2000;  162 837-843
• 27 Kollef M H, Ward S, Sherman G. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices.  Crit Care Med . 2000;  28 3456-3464
• 28 Raymond D P, Pelletier S J, Crabtree T D. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit.  Crit Care Med . 2001;  29 1101-1108
• 29 Pestotnik S L, Classen D C, Evans R S, Burke J P. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes.  Ann Intern Med . 1996;  124 884-890
• 30 Leibovici L, Gitelman V, Yehezkelli Y. Improving empirical antibiotic treatment: prospective, nonintervention testing of a decision support system.  J Intern Med . 1997;  242 395-400
• 31 Evans R S, Classen D C, Pestotnik S L, Lundsgaarde H P, Burke J P. Improving empiric antibiotic selection using computer decision support.  Arch Intern Med . 1994;  154 878-884
• 32 Gross P A. The potential for clinical guidelines to impact appropriate antimicrobial agent use.  Infect Dis Clin North Am . 1997;  11 803-812
• 33 Gonzales R, Steiner J F, Lum A, Barrett Jr H P. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults.  JAMA . 1999;  281 1512-1519
• 34 Evans R S, Pestotnik S L, Classen D C, Burke J P. Evaluation of a computer-assisted antibiotic-dose monitor.  Ann Pharmacother . 1999;  33 1026-1031
• 35 Kollef M H, Fraser V J. Antibiotic resistance in the intensive care unit.  Ann Intern Med . 2001;  134 298-314
• 36 Watkins C, Harvey I, Langley C, Gray S, Faulkner A. General practitioners' use of guidelines in the consultation and their attitudes to them.  Br J Gen Pract . 1999;  49 11-15
• 37 Rice L B, Eckstein E C, DeVente J, Shlaes D M. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center.  Clin Infect Dis . 1996;  23 118-124
• 38 McGowan Jr E J, Gerding D N. Does antibiotic restriction prevent resistance?.  New Horiz . 1996;  4 370-376
• 39 Dominguez E A, Smith T L, Reed E, Sanders C C, Sanders Jr E W. A pilot study of antibiotic cycling in a hematology-oncology unit.  Infect Control Hosp Epidemiol . 2000;  S4-S8